Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 13, 2013 - Issue 9
Submit an article Journal homepage
461
Views
10
CrossRef citations to date
0
Altmetric
Theme: Leukemia & Lymphoma - Review

Elotuzumab and daratumumab: emerging new monoclonal antibodies for multiple myeloma

Junya KurodaDepartment of Medicine, Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, JapanCorrespondence[email protected]
,
Hisao NagoshiDepartment of Medicine, Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan
,
Yuji ShimuraDepartment of Medicine, Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan
&
Masafumi TaniwakiDepartment of Medicine, Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan
Pages 1081-1088 | Published online: 10 Jan 2014

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Junya Kuroda, Tsutomu Kobayashi & Masafumi Taniwaki. (2015) Prognostic indicators of lenalidomide for multiple myeloma: consensus and controversy. Expert Review of Anticancer Therapy 15:7, pages 787-804.
Read now
Claudia Andreu-Vieyra & James R Berenson. (2014) Carfilzomib in multiple myeloma. Expert Opinion on Biological Therapy 14:11, pages 1685-1699.
Read now
Janice M Reichert, Alain Beck, Alexey A Lugovskoy, Thierry Wurch, Steven Coats & Randall J Brezski. (2014) 9th Annual European Antibody Congress, November 11–13, 2013, Geneva, Switzerland. mAbs 6:2, pages 309-326.
Read now

Articles from other publishers (7)

Congcong Cao, Xin Zhou & Qun Ma. (2021) Daratumumab provides a survival benefit in relapsed and refractory Multiple Myeloma, independent of baseline clinical characteristics: A meta‐analysis. Pharmacology Research & Perspectives 9:4.
Crossref
Yin Gao, Peng Fang, Wen-Jin Li, Jian Zhang, Guang-Ping Wang, Duan-Feng Jiang & Fang-Ping Chen. (2020) LncRNA NEAT1 sponges miR-214 to regulate M2 macrophage polarization by regulation of B7-H3 in multiple myeloma. Molecular Immunology 117, pages 20-28.
Crossref
Sagar Lonial, Brendan M Weiss, Saad Z Usmani, Seema Singhal, Ajai Chari, Nizar J Bahlis, Andrew Belch, Amrita Krishnan, Robert A Vescio, Maria Victoria Mateos, Amitabha Mazumder, Robert Z Orlowski, Heather J Sutherland, Joan Bladé, Emma C Scott, Albert Oriol, Jesus Berdeja, Mecide Gharibo, Don A Stevens, Richard LeBlanc, Michael Sebag, Natalie Callander, Andrzej Jakubowiak, Darrell White, Javier de la Rubia, Paul G Richardson, Steen Lisby, Huaibao Feng, Clarissa M Uhlar, Imran Khan, Tahamtan Ahmadi & Peter M Voorhees. (2016) Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial. The Lancet 387:10027, pages 1551-1560.
Crossref
Muhammad Husnain, Sandra Kurtin, Nikki Barkett, Irbaz Bin Riaz & Amit Agarwal. (2016) Refractory IgD Multiple Myeloma Treated with Daratumumab: A Case Report and Literature Review. Case Reports in Oncological Medicine 2016, pages 1-4.
Crossref
Liang Wang, Hua Wang, Peng-fei Li, Yue Lu, Zhong-jun Xia, Hui-qiang Huang & Yu-jing Zhang. (2015) CD38 expression predicts poor prognosis and might be a potential therapy target in extranodal NK/T cell lymphoma, nasal type. Annals of Hematology 94:8, pages 1381-1388.
Crossref
Yoshiaki Chinen, Junya Kuroda, Yuji Shimura, Hisao Nagoshi, Miki Kiyota, Mio Yamamoto-Sugitani, Shinsuke Mizutani, Natsumi Sakamoto, Masaki Ri, Eri Kawata, Tsutomu Kobayashi, Yosuke Matsumoto, Shigeo Horiike, Shinsuke Iida & Masafumi Taniwaki. (2014) Phosphoinositide Protein Kinase PDPK1 Is a Crucial Cell Signaling Mediator in Multiple Myeloma. Cancer Research 74:24, pages 7418-7429.
Crossref
Marko Salmi & Sirpa Jalkanen. (2014) Ectoenzymes in leukocyte migration and their therapeutic potential. Seminars in Immunopathology 36:2, pages 163-176.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.